Patent · US Active

Methods for prediction of clinical outcome to epidermal growth factor receptor inhibitors by non-small cell lung cancer patients

US9434994B2 · kind B2 · utility

0Cited by
18References
1Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 5, 2012
Grant dateSep 6, 2016
Priority date
Expiry dateJul 5, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/158
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Disclosed are methods to obtain an expression score to evaluate gene expression in a tissue specimen obtained from a person having or suspected of having cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.